Revenue of domestic API firms to see 7-8 pc increase by 2029: Report

The revenue of domestic active pharmaceutical ingredients (API) producers in India is projected to grow by 7-8% annually by 2029, according to a report by ICRA. The rating agency estimates that revenues will increase from USD 13-14 billion in 2023, driven by the pharmaceutical formulations industry and factors like an aging population, rising chronic diseases, and contract manufacturing demand. The operating profit margins of API firms are expected to improve in FY2025. Despite past challenges, including volatile earnings due to rising raw material costs and supply chain issues, the industry is poised for steady growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LqUdHJ9
via IFTTT

Read More

Dr Reddy's gets establishment inspection report from USFDA for Visakhapatnam units

Dr Reddy's Laboratories Ltd has obtained an Establishment Inspection Report from the USFDA for its Duvvada units, now classified as Voluntary Action Indicated. The units underwent an inspection from May 8 to May 17, 2024, which led to a Form 483 with observations. Dr Reddy’s planned to resolve the issues within the given time.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AqXWD6l
via IFTTT

Read More

As monsoon takes hold, anti-infective, respiratory drugs' demand surges

Monsoon led to a surge in demand for respiratory, anti-infective, and anti-malarial products. The respiratory market saw a notable increase in Poractant Alfa usage. Anti-malaria medicines experienced significant growth, driven by seasonal patterns. Core therapeutic areas like cardiac, respiratory, and gastro contributed to the overall market growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xH9JzqL
via IFTTT

Read More

What not to drink: 7 beverages that can worsen fatty liver

If you're looking to manage or avoid fatty liver, it's important to be cautious about your drink choices. Here are seven drinks that are generally considered worse for fatty liver:

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/egYRT6t
via IFTTT

Read More

At over 10 cr, India’s diabetic population is surging, yet the country lags behind in prescribing new medicines

Priya Rao experienced confusion and worry after fainting and receiving different diabetic medications from two doctors. The first doctor followed global guidelines, while the second used Indian ones, stabilizing her condition. The case underscores different diabetic treatment protocols and the importance of tailored patient care in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2wdsQBP
via IFTTT

Read More

Explore lesser-known Indian nuts: Chilgoza, Chiraunji & their benefits

India boasts a rich tradition of nuts in cooking and medicine. While almonds and cashews are common, lesser-known nuts like chilgoza and chiraunji offer unique flavors and significant health benefits.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FpzmhJD
via IFTTT

Read More

Hospital chain Medanta lines up Rs 1,200 crore for Mumbai entry

Global Health, operator of Medanta hospitals, is set to build a 500-bed super specialty hospital in Mumbai with an investment of ₹1,200 crore. The project, funded equally by debt and internal accruals, will be completed in 3-4 years. Medanta recently acquired the land in Oshiwara through a public auction.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fdCMeVA
via IFTTT

Read More